# The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC

> **NCT04800497** · — · UNKNOWN · sponsor: **University of Milano Bicocca** · enrollment: 70 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Recurrent Hepatocellular Carcinoma
- Circulating Tumor Cell

## Interventions

- **PROCEDURE:** Hepatic resection

## Key facts

- **NCT ID:** NCT04800497
- **Lead sponsor:** University of Milano Bicocca
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-07
- **Primary completion:** 2026-02-07
- **Final completion:** 2026-02-07
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-01-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04800497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04800497, "The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04800497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*